Subcutaneous panniculitis-like T-cell lymphoma: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{DiseaseDisorder infobox |
{{SI}}
  Name          = Subcutaneous panniculitis-like T-cell lymphoma|
  ICD10          = {{ICD10|C|84|7|c|81}} |
  OMIM          = |
  MedlinePlus    = |
  eMedicineSubj  = |
  eMedicineTopic = |
}}
{{CMG}}


{{SK}}
'''For patient information, click [[Insert page name here (patient information)|Insert page name here]]'''


== [[Subcutaneous panniculitis-like T-cell lymphoma overview|Overview]] ==
{{CMG}}; {{AE}} {{AS}}


== [[Subcutaneous panniculitis-like T-cell lymphoma historical perspective|Historical Perspective]]==
{{SK}}


== [[Subcutaneous panniculitis-like T-cell lymphoma classification|Classification]] ==
== Overview ==


== [[Subcutaneous panniculitis-like T-cell lymphoma pathophysiology|Pathophysiology]] ==
== Pathophysiology==
=== Associated Conditions===


== [[Subcutaneous panniculitis-like T-cell lymphoma causes|Causes]] ==
===Microscopic Pathology===


== [[Subcutaneous panniculitis-like T-cell lymphoma diagnosis|Differentiating Subcutaneous panniculitis-like T-cell lymphoma from other Diseases]] ==
==Causes==
There are no established causes for subcutaneous panniculitis-like T-cell lymphoma.
==Differentiating type page name here from other Diseases==
Subcutaneous panniculitis-like T-cell lymphoma must be differentiated from other diseases such as:
* [[Benign panniculitis]]
* [[Cutaneous T-cell lymphoma]]
* [[Extranodal NK/T cell lymphoma]]
== Epidemiology and Demographics ==
===Age===
The incidence of subcutaneous panniculitis-like T-cell lymphoma increases with age; the median age at diagnosis is 35 years.
===Gender===
Females are more commonly affected with subcutaneous panniculitis-like T-cell lymphoma than males.
== Risk Factors ==
There are no established risk factors for subcutaneous panniculitis-like T-cell lymphoma.
== Screening ==
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for subcutaneous panniculitis-like T-cell lymphoma.<ref name=uspreventive> Recommendations. U.S Preventive Services Task Force.  Accessed on March 8, 2016</ref>
== Natural History, Complications and Prognosis==


== [[Subcutaneous panniculitis-like T-cell lymphoma epidemiology and demographics|Epidemiology and Demographics]]==
== Diagnosis ==
===Staging===
Staging for subcutaneous panniculitis-like T-cell lymphoma is provided in the following table:<ref>{{Cite journal| doi = 10.1200/JCO.2013.54.8800| issn = 1527-7755| volume = 32| issue = 27| pages = 3059–3068| last1 = Cheson| first1 = Bruce D.| last2 = Fisher| first2 = Richard I.| last3 = Barrington| first3 = Sally F.| last4 = Cavalli| first4 = Franco| last5 = Schwartz| first5 = Lawrence H.| last6 = Zucca| first6 = Emanuele| last7 = Lister| first7 = T. Andrew| last8 = Alliance, Australasian Leukaemia and Lymphoma Group| last9 = Eastern Cooperative Oncology Group| last10 = European Mantle Cell Lymphoma Consortium| last11 = Italian Lymphoma Foundation| last12 = European Organisation for Research| last13 = Treatment of Cancer/Dutch Hemato-Oncology Group| last14 = Grupo Español de Médula Ósea| last15 = German High-Grade Lymphoma Study Group| last16 = German Hodgkin's Study Group| last17 = Japanese Lymphorra Study Group| last18 = Lymphoma Study Association| last19 = NCIC Clinical Trials Group| last20 = Nordic Lymphoma Study Group| last21 = Southwest Oncology Group| last22 = United Kingdom National Cancer Research Institute| title = Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification| journal = Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology| date = 2014-09-20| pmid = 25113753}}</ref>


== [[Subcutaneous panniculitis-like T-cell lymphoma risk factors|Risk Factors]] ==
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
|+ '''Revised staging system for primary nodal lymphomas (Lugano classification)'''
! style="background: #4479BA; color:#FFF;" | Stage
! style="background: #4479BA; color:#FFF;" | Involvement
! style="background: #4479BA; color:#FFF;" | Extranodal (E) status
|-
| style="padding: 5px 5px; background: #DCDCDC;" colspan=3 | '''Limited'''
|-
| style="padding: 5px 5px; background: #F5F5F5;" | Stage I
| style="padding: 5px 5px; background: #F5F5F5;" | One node or a group of adjacent nodes
| style="padding: 5px 5px; background: #F5F5F5;" | Single extranodal lesions without nodal involvement
|-
| style="padding: 5px 5px; background: #F5F5F5;" | Stage II
| style="padding: 5px 5px; background: #F5F5F5;" | Two or more nodal groups on the same side of the diaphragm
| style="padding: 5px 5px; background: #F5F5F5;" | Stage I or II by nodal extent with limited contiguous extranodal involvement
|-
| style="padding: 5px 5px; background: #F5F5F5;" | Stage II bulky
| style="padding: 5px 5px; background: #F5F5F5;" | II as above with "bulky" disease
| style="padding: 5px 5px; background: #F5F5F5;" | Not applicable
|-
| style="padding: 5px 5px; background: #DCDCDC;" colspan=3 | '''Advanced'''
|-
| style="padding: 5px 5px; background: #F5F5F5;" | Stage III
| style="padding: 5px 5px; background: #F5F5F5;" | Nodes on both sides of the diaphragm; nodes above the diaphragm with spleen involvement
| style="padding: 5px 5px; background: #F5F5F5;" | Not applicable
|-
| style="padding: 5px 5px; background: #F5F5F5;" | Stage IV
| style="padding: 5px 5px; background: #F5F5F5;" | Additional noncontiguous extralymphatic involvement
| style="padding: 5px 5px; background: #F5F5F5;" | Not applicable
|}


== [[Subcutaneous panniculitis-like T-cell lymphoma, complications and prognosis|Natural History, Complications and Prognosis]] ==
=== Symptoms ===
Symptoms of the subcutaneous panniculitis-like T-cell lymphoma include:
* [[Fever]]
* [[Weight loss]]
* [[Night sweats]]
* Painless swelling in the neck, axilla, groin, thorax, and abdomen
=== Physical Examination ===
====Vitals====
* [[Fever]] is often present
====Skin====
* Subcutaneous nodules
====HEENT====
* [[Lymphadenopathy|Cervical lymphadenopathy]]
====Thorax====
* Thoracic masses suggestive of [[Lymphadenopathy|central lymphadenopathy]]
====Abdomen====
* [[Abdominal mass]]es suggestive of [[Lymphadenopathy|central lymphadenopathy]]
* [[Hepatosplenomegaly]]
====Extremities====
* [[Lymphadenopathy|Peripheral lymphadenopathy]]
===Laboratory Findings ===
Laboratory tests for subcutaneous panniculitis-like T-cell lymphoma include:
* [[Complete blood count]] (CBC): cytopenia
* Blood chemistry studies: Increased [[liver function tests]]
* Cytogenetic analysis
* [[Flow cytometry]]
====Biopsy====
Lymph node or bone marrow biopsy is diagnostic of subcutaneous panniculitis-like T-cell lymphoma.
====CT ====
[[CT]] scan may be helpful in the diagnosis of subcutaneous panniculitis-like T-cell lymphoma.
==== MRI ====
[[MRI]] scan may be helpful in the diagnosis of subcutaneous panniculitis-like T-cell lymphoma.
==== Other Imaging Findings ====
[[PET]] scan may be helpful in the diagnosis of subcutaneous panniculitis-like T-cell lymphoma.
==Treatment==


== Diagnosis ==
===Medical Therapy===
[[Subcutaneous panniculitis-like T-cell lymphoma history and symptoms|History and Symptoms]] | [[Subcutaneous panniculitis-like T-cell lymphoma physical examination|Physical Examination]] | [[Subcutaneous panniculitis-like T-cell lymphoma laboratory findings|Laboratory Findings]] | [[Subcutaneous panniculitis-like T-cell lymphoma CT|CT]] | [[Subcutaneous panniculitis-like T-cell lymphoma other diagnostic studies|Other Diagnostic Studies]]


== Treatment ==
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
|+ '''Treatment of subcutaneous panniculitis-like T-cell lymphoma<ref name= canadiancancer>Subcutaneous panniculitis-like T-cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/subcutaneous-panniculitis-like-t-cell-lymphoma/?region=nb. Accessed on March 8, 2016 </ref>
! style="background: #4479BA; color:#FFF;" | Therapy
! style="background: #4479BA; color:#FFF;" | Description
|-
| style="padding: 5px 5px; background: #DCDCDC;" | [[Chemotherapy]]
| style="padding: 5px 5px; background: #F5F5F5;" |
* Combination therapy :
:* CHOP – [[Cyclophosphamide]] {{and}} [[Doxorubicin]] {{and}} [[Vincristine]] {{and}} [[Prednisone]]
|-
| style="padding: 5px 5px; background: #DCDCDC;" | [[Radiation therapy]]
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[External beam radiation therapy]] may be used to treat the lymph nodes.
|-
| style="padding: 5px 5px; background: #DCDCDC;" | [[Stem cell transplant]]
| style="padding: 5px 5px; background: #F5F5F5;" |
* May be used in some people with subcutaneous panniculitis-like T-cell lymphoma when their lymphoma recurs after treatment.
|}


[[Subcutaneous panniculitis-like T-cell lymphoma medical therapy|Medical Therapy]] | [[Subcutaneous panniculitis-like T-cell lymphoma surgery|Surgery]] | [[Subcutaneous panniculitis-like T-cell lymphoma primary prevention|Primary Prevention]] | [[Subcutaneous panniculitis-like T-cell lymphoma secondary prevention|Secondary Prevention]] | [[Subcutaneous panniculitis-like T-cell lymphoma future or investigational therapies|Future or Investigational Therapies]] | [[Subcutaneous panniculitis-like T-cell lymphoma cost-effectiveness of therapy | Cost Effectiveness of Therapy]]
==References==
{{Reflist|2}}


==Case Studies==
[[Category:Disease]]
:[[Subcutaneous panniculitis-like T-cell lymphoma case study one|Case #1]]
[[Category:Oncology]]

Revision as of 15:32, 8 March 2016

WikiDoc Resources for Subcutaneous panniculitis-like T-cell lymphoma

Articles

Most recent articles on Subcutaneous panniculitis-like T-cell lymphoma

Most cited articles on Subcutaneous panniculitis-like T-cell lymphoma

Review articles on Subcutaneous panniculitis-like T-cell lymphoma

Articles on Subcutaneous panniculitis-like T-cell lymphoma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Subcutaneous panniculitis-like T-cell lymphoma

Images of Subcutaneous panniculitis-like T-cell lymphoma

Photos of Subcutaneous panniculitis-like T-cell lymphoma

Podcasts & MP3s on Subcutaneous panniculitis-like T-cell lymphoma

Videos on Subcutaneous panniculitis-like T-cell lymphoma

Evidence Based Medicine

Cochrane Collaboration on Subcutaneous panniculitis-like T-cell lymphoma

Bandolier on Subcutaneous panniculitis-like T-cell lymphoma

TRIP on Subcutaneous panniculitis-like T-cell lymphoma

Clinical Trials

Ongoing Trials on Subcutaneous panniculitis-like T-cell lymphoma at Clinical Trials.gov

Trial results on Subcutaneous panniculitis-like T-cell lymphoma

Clinical Trials on Subcutaneous panniculitis-like T-cell lymphoma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Subcutaneous panniculitis-like T-cell lymphoma

NICE Guidance on Subcutaneous panniculitis-like T-cell lymphoma

NHS PRODIGY Guidance

FDA on Subcutaneous panniculitis-like T-cell lymphoma

CDC on Subcutaneous panniculitis-like T-cell lymphoma

Books

Books on Subcutaneous panniculitis-like T-cell lymphoma

News

Subcutaneous panniculitis-like T-cell lymphoma in the news

Be alerted to news on Subcutaneous panniculitis-like T-cell lymphoma

News trends on Subcutaneous panniculitis-like T-cell lymphoma

Commentary

Blogs on Subcutaneous panniculitis-like T-cell lymphoma

Definitions

Definitions of Subcutaneous panniculitis-like T-cell lymphoma

Patient Resources / Community

Patient resources on Subcutaneous panniculitis-like T-cell lymphoma

Discussion groups on Subcutaneous panniculitis-like T-cell lymphoma

Patient Handouts on Subcutaneous panniculitis-like T-cell lymphoma

Directions to Hospitals Treating Subcutaneous panniculitis-like T-cell lymphoma

Risk calculators and risk factors for Subcutaneous panniculitis-like T-cell lymphoma

Healthcare Provider Resources

Symptoms of Subcutaneous panniculitis-like T-cell lymphoma

Causes & Risk Factors for Subcutaneous panniculitis-like T-cell lymphoma

Diagnostic studies for Subcutaneous panniculitis-like T-cell lymphoma

Treatment of Subcutaneous panniculitis-like T-cell lymphoma

Continuing Medical Education (CME)

CME Programs on Subcutaneous panniculitis-like T-cell lymphoma

International

Subcutaneous panniculitis-like T-cell lymphoma en Espanol

Subcutaneous panniculitis-like T-cell lymphoma en Francais

Business

Subcutaneous panniculitis-like T-cell lymphoma in the Marketplace

Patents on Subcutaneous panniculitis-like T-cell lymphoma

Experimental / Informatics

List of terms related to Subcutaneous panniculitis-like T-cell lymphoma

For patient information, click Insert page name here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Synonyms and keywords:

Overview

Pathophysiology

Associated Conditions

Microscopic Pathology

Causes

There are no established causes for subcutaneous panniculitis-like T-cell lymphoma.

Differentiating type page name here from other Diseases

Subcutaneous panniculitis-like T-cell lymphoma must be differentiated from other diseases such as:

Epidemiology and Demographics

Age

The incidence of subcutaneous panniculitis-like T-cell lymphoma increases with age; the median age at diagnosis is 35 years.

Gender

Females are more commonly affected with subcutaneous panniculitis-like T-cell lymphoma than males.

Risk Factors

There are no established risk factors for subcutaneous panniculitis-like T-cell lymphoma.

Screening

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for subcutaneous panniculitis-like T-cell lymphoma.[1]

Natural History, Complications and Prognosis

Diagnosis

Staging

Staging for subcutaneous panniculitis-like T-cell lymphoma is provided in the following table:[2]

Revised staging system for primary nodal lymphomas (Lugano classification)
Stage Involvement Extranodal (E) status
Limited
Stage I One node or a group of adjacent nodes Single extranodal lesions without nodal involvement
Stage II Two or more nodal groups on the same side of the diaphragm Stage I or II by nodal extent with limited contiguous extranodal involvement
Stage II bulky II as above with "bulky" disease Not applicable
Advanced
Stage III Nodes on both sides of the diaphragm; nodes above the diaphragm with spleen involvement Not applicable
Stage IV Additional noncontiguous extralymphatic involvement Not applicable

Symptoms

Symptoms of the subcutaneous panniculitis-like T-cell lymphoma include:

Physical Examination

Vitals

Skin

  • Subcutaneous nodules

HEENT

Thorax

Abdomen

Extremities

Laboratory Findings

Laboratory tests for subcutaneous panniculitis-like T-cell lymphoma include:

Biopsy

Lymph node or bone marrow biopsy is diagnostic of subcutaneous panniculitis-like T-cell lymphoma.

CT

CT scan may be helpful in the diagnosis of subcutaneous panniculitis-like T-cell lymphoma.

MRI

MRI scan may be helpful in the diagnosis of subcutaneous panniculitis-like T-cell lymphoma.

Other Imaging Findings

PET scan may be helpful in the diagnosis of subcutaneous panniculitis-like T-cell lymphoma.

Treatment

Medical Therapy

Treatment of subcutaneous panniculitis-like T-cell lymphoma[3]
Therapy Description
Chemotherapy
  • Combination therapy :
Radiation therapy
Stem cell transplant
  • May be used in some people with subcutaneous panniculitis-like T-cell lymphoma when their lymphoma recurs after treatment.

References

  1. Recommendations. U.S Preventive Services Task Force. Accessed on March 8, 2016
  2. Cheson, Bruce D.; Fisher, Richard I.; Barrington, Sally F.; Cavalli, Franco; Schwartz, Lawrence H.; Zucca, Emanuele; Lister, T. Andrew; Alliance, Australasian Leukaemia and Lymphoma Group; Eastern Cooperative Oncology Group; European Mantle Cell Lymphoma Consortium; Italian Lymphoma Foundation; European Organisation for Research; Treatment of Cancer/Dutch Hemato-Oncology Group; Grupo Español de Médula Ósea; German High-Grade Lymphoma Study Group; German Hodgkin's Study Group; Japanese Lymphorra Study Group; Lymphoma Study Association; NCIC Clinical Trials Group; Nordic Lymphoma Study Group; Southwest Oncology Group; United Kingdom National Cancer Research Institute (2014-09-20). "Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification". Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 32 (27): 3059–3068. doi:10.1200/JCO.2013.54.8800. ISSN 1527-7755. PMID 25113753.
  3. Subcutaneous panniculitis-like T-cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/subcutaneous-panniculitis-like-t-cell-lymphoma/?region=nb. Accessed on March 8, 2016